Related references
Note: Only part of the references are listed.Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia
Marcus Y. Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure
Magnus Unemo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting
David M. Whiley et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone
Makoto Ohnishi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
UK national guideline for the management of gonorrhoea in adults, 2011
C. Bignell et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2011)
Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods
John Tapsall et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Species status of Neisseria gonorrhoeae:: evolutionary and epidemiological inferences from multilocus sequence typing
Julia S. Bennett et al.
BMC BIOLOGY (2007)
Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone
David M. Whiley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area
IMC Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Share Paper
